Characteristics | Study cohort | Euglycemic | IR | T2D | ANOVA F-value | Kruskal–Wallis Chi-squared | p-value |
---|---|---|---|---|---|---|---|
Heart Rate (bpm) (T0) | 68 [60–75] | 65 [60–73, 5] | 68 [62–77]* | 72 [64–76]* | 5.5 |  |  < 0.01 |
sPO2 (%) (T0) | 97 [96–98] | 97 [95–98] | 97 [96–98] | 97 [96–98] | 0.5 |  | 0.6 |
Fatigue Borg Scale (T0) | 0 [0–1] | 0 [0–0.6] | 0 [0–1] | 0 [0–1] | – | 1.8 | – |
Distance (m) | 380 ± 102 | 397 ± 101 | 386 ± 107 | 352 ± 93*,§ | 3.6 |  |  < 0.01 |
sPO2 MAX (%) | 98 [97–99] | 98 [97–99] | 98 [97–98] | 98 [97–98] | 0.8 |  | 0.45 |
sPO2MIN (%) | 96 [94–97] | 95 [94–97] | 96 [94–97] | 96]94–97] | 0.3 |  | 0.8 |
HR MAX (bpm) | 85 [75–97.2] | 84 [73–98] | 87 [76–97] | 85 [77–94] | 0.9 |  | 0.4 |
Heart Rate (end) (bpm) | 80 [70–90] | 76 [68–86.5] | 80 [70–93] | 81 [72–92] | 2.3 |  | 0.1 |
sPO2 (end) (%) | 97 [95–98] | 97 [95–98] | 97 [96–98] | 97 [95–98] | 0.3 |  | 0.7 |
Fatigue Borg Scale (End) | 2 [1–3] | 1 [0.5–3] | 2 [1–4] | 2 [1–3] |  | 3 | 0.2 |